Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Moodys
Healthtrust
Federal Trade Commission
Deloitte
US Army
Boehringer Ingelheim
Merck
Citi

Generated: December 11, 2018

DrugPatentWatch Database Preview

Drug Sales Trends for ENBREL SRCLK

« Back to Dashboard

Payment Methods and Pharmacy Types for ENBREL SRCLK (2016)

Revenues by Pharmacy Type

Pharmacy Type Revenues
MAIL-ORDER $240,281,808
INSIDE ANOTHER STORE $69,370,864
[disabled in preview] $273,643,850
This preview shows a limited data set
Subscribe for full access, or try a Trial

Units Sold by Pharmacy Type

Pharmacy Type Units
MAIL-ORDER 246,994
INSIDE ANOTHER STORE 17,762
[disabled in preview] 167,383
This preview shows a limited data set
Subscribe for full access, or try a Trial

Revenues by Payment Method

Payment Method Revenues
MEDICARE $16,886,982
OTHER PRIVATE $69,015,624
[disabled in preview] $497,393,915
This preview shows a limited data set
Subscribe for full access, or try a Trial
Drug Sales Revenue Trends for ENBREL SRCLK
Drug Units Sold Trends for ENBREL SRCLK

Annual Sales Revenues and Units Sold for ENBREL SRCLK

These sales figures are drawn from a US national survey of drug expenditures
Drug Name Revenues (USD) Units Year
ENBREL SRCLK ➤ Try a Free Trial ➤ Try a Free Trial 2016
ENBREL SRCLK ➤ Try a Free Trial ➤ Try a Free Trial 2015
ENBREL SRCLK ➤ Try a Free Trial ➤ Try a Free Trial 2014
ENBREL SRCLK ➤ Try a Free Trial ➤ Try a Free Trial 2013
ENBREL SRCLK ➤ Try a Free Trial ➤ Try a Free Trial 2012
ENBREL SRCLK ➤ Try a Free Trial ➤ Try a Free Trial 2011
Drug Name Revenues (USD) Units Year

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
UBS
Express Scripts
Dow
Merck
AstraZeneca
McKinsey
Citi
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.